ITIrwin I. Tendler

Irwin I. Tendler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irwin I. Tendler has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Petr Bruza

    Dartmouth College

    8 shared publications
  • Michael Jermyn

    Thayer School of Engineering, Dartmouth College, Hanover, NH, USA

    6 shared publications
  • Brian W. Pogue

    Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States

    5 shared publications
  • David J. Gladstone

    Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire; Department of Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

    5 shared publications
  • Lesley A Jarvis

    Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA

    4 shared publications
  • Lesley A. Jarvis

    Department of Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA

    4 shared publications

Latest Publications

  • Recent Advances and Clinical Applications of Plastic Scintillators in the Field of Radiation Therapy

    by Sam Beddar, Irwin Tendler, François Therriault-Proulx, Louis Archambault, Luc Beaulieu


  • Image quality evaluation of projection- and depth dose-based approaches to integrating proton radiography using a monolithic scintillator detector

    by Irwin Tendler, Daniel G Robertson, Chinmay Dilip Darne, Rajesh Panthi, Fahed Alsanea, Charles-Antoine Collins-Fekete, Sam Beddar

    The purpose of this study is to compare the image quality of an integrating proton radiography (PR) system, composed of a monolithic scintillator and two digital cameras, using integral lateral-dose and integral depth-dose image reconstruction techniques. Monte Carlo simulations were used to obtain the energy deposition in a 3D monolithic scintillator detector (30 × 30 × 30 cm 3 poly vinyl toluene organic scintillator) to create radiographs of various phantoms—a slanted aluminum cube for spatial resolution analysis and a Las Vegas phantom for contrast analysis. The light emission of the scintillator was corrected using Birks scintillation model. We compared two integrating PR methods and the expected results from an idealized proton tracking radiography system. Four different image reconstruction methods were utilized in this study: integral scintillation light projected from the beams-eye view, depth-dose based reconstruction methods both with and without optimization, and single particle tracking PR was used for reference data. Results showed that heterogeneity artifact due to medium-interface mismatch was identified from the Las Vegas phantom simulated in air. Spatial resolution was found to be highest for single-event reconstruction. Contrast levels, ranked from best to worst, were found to correspond to particle tracking, optimized depth-dose, depth-dose, and projection-based image reconstructions. The image quality of a monolithic scintillator integrating PR system was sufficient to warrant further exploration. These results show promise for potential clinical use as radiographic techniques for visualizing internal patient anatomy during proton radiotherapy.


  • Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease

    by Duygu Sezen, Vivek Verma, Kewen He, Chike O. Abana, Hampartsaum Barsoumian, Matthew S. Ning, Chad Tang, Pervin Hurmuz, Nahum Puebla-Osorio, Dawei Chen, et al.


  • Cherenkov and Scintillation Imaging Dosimetry

    by Rachael L. Hachadorian, Irwin I. Tendler, Brian W. Pogue

    Until recently, radiotherapy in medicine has been practiced with the concept that the radiation beam and dose delivery could only be verified by measurement probe or device, which directly samples the field. Imaging via film or external portal imaging devices is most common, however, these only sample the field and not the dose delivered to the subject. The use of light emission from therapeutic-range radiation also provides a signal which can be used to visualize the beam in 2D and 3D in real-time. When planned carefully, it can also serve as a surrogate for the deposited dose. By applying the appropriate time gating and sensitivity, this can provide the clinical physics or radiotherapy teams with potentially video-rate feedback of the patients' treatment. The clinical utility is still developing as optimal camera choices are refined and optical imaging geometries are tested in clinical trials. The choice of the type of radioluminescence signal to image will alter how the imaging is done and what the application would be. In this chapter, the use of imaging to capture Cherenkov emission or scintillation emission is discussed from fundamental emission characteristics to how the signal can be used in both quality audit and delivery verification applications.


  • Open Access

    Technical Note: A novel dosimeter improves total skin electron therapy surface dosimetry workflow

    by Irwin I. Tendler, Petr Bruza, Michael Jermyn, Jennifer Soter, Gregory Sharp, Benjamin Williams, Lesley A. Jarvis, Brian Pogue, David J. Gladstone

    Purpose The novel scintillator‐based system described in this study is capable of accurately and remotely measuring surface dose during Total Skin Electron Therapy (TSET); this dosimeter does not require post‐exposure processing or annealing and has been shown to be re‐usable, resistant to radiation damage, have minimal impact on surface dose, and reduce chances of operator error compared to existing technologies e.g. optically stimulated luminescence detector (OSLD). The purpose of this study was to quantitatively analyze the workflow required to measure surface dose using this new scintillator dosimeter and compare it to that of standard OSLDs. Methods Disc‐shaped scintillators were attached to a flat‐faced phantom and a patient undergoing TSET. Light emission from these plastic discs was captured using a time‐gated, intensified, camera during irradiation and converted to dose using an external calibration factor. Time required to complete each step (daily QA, dosimeter preparation, attachment, removal, registration, and readout) of the scintillator and OSLD surface dosimetry workflows was tracked. Results In phantoms, scintillators and OSLDs surface doses agreed within 3% for all data points. During patient imaging it was found that surface dose measured by OSLD and scintillator agreed within 5% and 3% for 35/35 and 32/35 dosimetry sites, respectively. The end‐to‐end time required to measure surface dose during phantom experiments for a single dosimeter was 78 and 202 sec for scintillator and OSL dosimeters, respectively. During patient treatment, surface dose was assessed at 7 different body locations by scintillator and OSL dosimeters in 386 and 754 sec, respectively. Conclusion Scintillators have been shown to report dose nearly twice as fast as OSLDs with substantially less manual work and reduced chances of human error. Scintillator dose measurements are automatically saved to an electronic patient file and images contain a permanent record of the dose delivered during treatment.


  • Tracking tumor radiotherapy response in vivo with Cherenkov-excited luminescence ink imaging

    by Jennifer A Soter, Ethan Phillip M LaRochelle, Brook K Byrd, Irwin I Tendler, Jason R Gunn, Boyu Meng, Rendall R Strawbridge, Dennis J Wirth, Scott C Davis, David J Gladstone, et al.

    Purpose: This study demonstrates remote imaging for in vivo detection of radiation-induced tumor microstructural changes by tracking the diffusive spread of injected intratumor UV excited tattoo ink using Cherenkov-excited luminescence imaging (CELI). Methods: Micro-liter quantities of luminescent tattoo ink with UV absorption and visible emission were injected at a depth of 2mm into mouse tumors prior to receiving a high dose treatment of radiation. X-rays from a clinical linear accelerator were used to excite phosphorescent compounds within the tattoo ink through Cherenkov emission. The in vivo phosphorescence was detected using a time-gated intensified CMOS camera immediately after injection, and then again at varying time points after the ink had broken down with the apoptotic tumor cells. ex vivo tumors were imaged post-mortem using hyperspectral cryo-fluorescence imaging to quantify necrosis and compared to Cherenkov-excited light imaging of diffusive ink spread measured in vivo. Results: Imaging of untreated control mice showed that ink distributions remained constant after four days with less than 3% diffusive spread measured using full width at 20% max. For all mice, in vivo CELI measurements matched within 12% of the values estimated by the high-resolution ex vivo sliced luminescence imaging of the tumors. The tattoo ink spread in treated mice was found to correlate well with the nonperfusion necrotic core volume (R2=0.92) but not well with total tumor volume changes (R2=0.34). Conclusion: In vivo and ex vivo findings indicate that the diffusive spread of the injected tattoo ink can be related to radiation-induced necrosis, independent of total tumor volume change. Tracking the diffusive spread of the ink allows for distinguishing between an increase in tumor size due to new cellular growth and an increase in tumor size due to edema. Furthermore, the imaging resolution of CELI allows for in vivo tracking of subtle microenvironmental changes which occur earlier than tumor shrinkage and this offers the potential for novel, minimally invasive radiotherapy response assay without interrupting a singular clinical workflow.


  • Open Access

    Experimentally Observed Cherenkov Light Generation in the Eye During Radiation Therapy

    by Irwin I. Tendler, Alan Hartford, Michael Jermyn, Ethan LaRochelle, Xu Cao, Victor Borza, Daniel Alexander, Petr Bruza, Jack Hoopes, Karen Moodie, et al.


  • Open Access

    Improvements to an optical scintillator imaging-based tissue dosimetry system

    by Irwin I. Tendler, Petr Bruza, Michael Jermyn, Antoine Fleury, Benjamin B. Williams, Lesley A. Jarvis, Brian W. Pogue, David J. Gladstone

    Previous work has shown that capturing optical emission from plastic discs attached directly to the skin can be a viable means to accurately measure surface dose during total skin electron therapy. This method can provide accurate dosimetric information rapidly and remotely without the need for postprocessing. The objective of this study was to: (1) improve the robustness and usability of the scintillators and (2) enhance sensitivity of the optical imaging system to improve scintillator emission detection as related to tissue surface dose. Baseline measurements of scintillator optical output were obtained by attaching the plastic discs to a flat tissue phantom and simultaneously irradiating and imaging them. Impact on underlying surface dose was evaluated by placing the discs on-top of the active element of an ionization chamber. A protective coating and adhesive backing were added to allow easier logistical use, and they were also subjected to disinfection procedures, while verifying that these changes did not affect the linearity of response with dose. The camera was modified such that the peak of detector quantum efficiency better overlapped with the emission spectra of the scintillating discs. Patient imaging was carried out and surface dose measurements were captured by the updated camera and compared to those produced by optically stimulated luminescence detectors (OSLD). The updated camera was able to measure surface dose with <3 % difference compared to OSLD–Cherenkov emission from the patient was suppressed and scintillation detection was enhanced by 25 × and 7 × , respectively. Improved scintillators increase underlying surface dose on average by 5.2 ± 0.1 % and light output decreased by 2.6 ± 0.3 % . Disinfection had <0.02 % change on scintillator light output. The enhanced sensitivity of the imaging system to scintillator optical emission spectrum can now enable a reduction in physical dimensions of the dosimeters without loss in ability to detect light output.


  • Assessment of imaging Cherenkov and scintillation signals in head and neck radiotherapy

    by Daniel A Alexander, Irwin I Tendler, Petr Bruza, Xu Cao, Philip E Schaner, Bethany S Marshall, Lesley A Jarvis, David J Gladstone, Brian W Pogue

    The goal of this study was to test the utility of time-gated optical imaging of head and neck (HN) radiotherapy treatments to measure surface dosimetry in real-time and inform possible interfraction replanning decisions. The benefit of both Cherenkov and scintillator imaging in HN treatments is direct daily feedback on dose, with no change to the clinical workflow. Emission from treatment materials was characterized by measuring radioluminescence spectra during irradiation and comparing emission intensities relative to Cherenkov emission produced in phantoms and scintillation from small plastic targets. HN treatment plans were delivered to a phantom with bolus and mask present to measure impact on signal quality. Interfraction superficial tumor reduction was simulated on a HN phantom, and cumulative Cherenkov images were analyzed in the region of interest (ROI). HN human patient treatment was imaged through the mask and compared with the dose distribution calculated by the treatment planning system. The relative intensity of radioluminescence from the mask was found to be within 30% of the Cherenkov emission intensity from tissue-colored clay. A strong linear relationship between normalized cumulative Cherenkov intensity and tumor size was established ( ). The presence of a mask above a scintillator ROI was found to decrease mean pixel intensity by >40% and increase distribution spread. Cherenkov imaging through mask material is shown to have potential for surface field verification and tracking of superficial anatomy changes between treatment fractions. Imaging of scintillating targets provides a direct imaging of surface dose on the patient and through transparent bolus material. The first imaging of a patient receiving HN radiotherapy was achieved with a signal map which qualitatively matches the surface dose plan.


  • Technical Note: Quality assurance and relative dosimetry testing of a 60Co total body irradiator using optical imaging

    by Irwin I. Tendler, Jeremy S. Bredfeldt, Rongxiao Zhang, Petr Bruza, Michael Jermyn, Brian W. Pogue, David J. Gladstone

    Purpose: The aim of this study was to create an optical imaging‐based system for quality assurance (QA) testing of a dedicated Co‐60 total body irradiation (TBI) machine. Our goal is to streamline the QA process by minimizing the amount time necessary for tests such as verification of dose rate and field homogeneity.Methods: Plastic scintillating rods were placed directly on the patient treatment couch of a dedicated TBI 60Co irradiator. A tripod‐mounted intensified camera was placed directly adjacent to the couch. Images were acquired over a 30‐s period once the cobalt source was fully exposed. Real‐time image filtering was used; cumulative images were flatfield corrected as well as background and darkfield subtracted. Scintillators were used to measure light‐radiation field correspondence, dose rate, field homogeneity, and symmetry. Dose rate effects were measured by modifying the height of the treatment couch and scintillator response was compared to ionization chamber (IC) measurements. Optically stimulated luminesce detector (OSLD) used as reference dosimeters during field symmetry and homogeneity testing.Results: The scintillator‐based system accurately reported changes in dose rate. When comparing normalized output values for IC vs scintillators over a range of source‐to‐surface distances, a linear relationship (R2 = 0.99) was observed. Normalized scintillator signal matched OSLD measurements with 60Co irradiator QA. We have shown that this technique can accurately measure field homogeneity, symmetry, light‐radiation field correspondence, and dose rate effects.